Literature DB >> 3338564

Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems.

D R Macallan1, G G Lunt, S Wonnacott, K L Swanson, H Rapoport, E X Albuquerque.   

Abstract

Specific high-affinity binding sites for 125I-alpha-bungarotoxin and (-)-[3H]nicotine have been measured in rat brain and locust (Schistocerca gregaria) ganglia. The binding sites for 125I-alpha-bungarotoxin had similar Kd values of 1.5 x 10(-9) and 0.8 x 10(-9) M for rat and locust preparations, respectively; the corresponding values for the (-)-[3H]nicotine-binding site were 9.3 x 10(-9) and 1.7 x 10(-7) M. Methyllycaconitine (MLA) potently inhibited 125I-alpha-bungarotoxin binding in both rat and locust. MLA was a less effective inhibitor of (-)-[3H]nicotine binding whereas (+)-anatoxin-a was a very potent inhibitor at this site in the rat but not in the locust. These data suggest that (+)-anatoxin-a is a useful probe for the high-affinity nicotine-binding receptor in vertebrate brain, whereas MLA is a preferential probe for the subclass of receptor that binds alpha-bungarotoxin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338564     DOI: 10.1016/0014-5793(88)81454-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  In vivo effects of the anatoxin-a on striatal dopamine release.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

3.  Nicotinic acetylcholine receptors are required for the conditioned reinforcing properties of sucrose-associated cues.

Authors:  Elin Löf; Peter Olausson; Rosita Stomberg; Jane R Taylor; Bo Söderpalm
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

4.  Similar nicotinic excitability responses across the developing hippocampal formation are regulated by small-conductance calcium-activated potassium channels.

Authors:  Beryl Y T Chung; Craig D C Bailey
Journal:  J Neurophysiol       Date:  2018-01-31       Impact factor: 2.714

Review 5.  Cholinergic regulation of epithelial ion transport in the mammalian intestine.

Authors:  C L Hirota; D M McKay
Journal:  Br J Pharmacol       Date:  2006-09-18       Impact factor: 8.739

6.  Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.

Authors:  D L Ridley; A Rogers; S Wonnacott
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 7.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

8.  Diastereoselective Synthesis of a Highly Substituted cis-Decahydroquinoline via a Knoevenagel Condensation.

Authors:  Junfeng Huang; Stephen C Bergmeier
Journal:  Tetrahedron       Date:  2008-06-30       Impact factor: 2.457

9.  Pharmacological and immunological identification of native alpha7 nicotinic receptors: evidence for homomeric and heteromeric alpha7 receptors.

Authors:  Raed A El-Hajj; Susan B McKay; Dennis B McKay
Journal:  Life Sci       Date:  2007-09-19       Impact factor: 5.037

10.  BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.

Authors:  T P Blackburn; G S Baxter; G A Kennett; F D King; D C Piper; G J Sanger; D R Thomas; N Upton; M D Wood
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.